Biotecnología

Why SLS stock is jumping premarket: SELLAS Life Sciences puts REGAL Phase 3 countdown back in play
···

Por qué las acciones de SLS suben en el premercado: SELLAS Life Sciences reactiva la cuenta regresiva del estudio REGAL de fase 3

SELLAS Life Sciences subía 3,4% a $4,29 en el premercado tras cerrar el viernes en $4,15, con alto volumen y volatilidad. Los operadores esperan resultados clave de su estudio de Fase 3 en LMA a mediados de marzo. El interés en corto alcanza el 24,4% del float, lo que podría aumentar la volatilidad. La empresa reportó $71,8 millones en efectivo al cierre de diciembre.
febrero 23, 2026

Stock Market Today

  • AI Economy Risks Creating a Global Permanent Underclass
    June 2, 2026, 9:57 AM EDT. The San Francisco Bay Area is undergoing an AI boom, driving massive wealth for top programmers with compensation packages reaching hundreds of millions of dollars. However, this surge is coupled with fears that AI automation, particularly in coding jobs, could create a permanent underclass as many startups fail. Economists debate AI's job impact, but Silicon Valley is pessimistic about widespread dislocation. While some countries like South Korea, Japan, and Taiwan are thriving in the AI supply chain, others such as those in Africa and Latin America face bleak prospects. The risk is a global economic divide as regions unable to participate in AI's growth may lack profits and tax revenue to fund social safety nets like universal basic income.